Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

The microbiome may be linked to hair loss and could be a target for new treatments.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Your skin is like an ecosystem, with its own community of microbes and substances that interact and affect its health.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

JAK inhibitors show promise for treating various skin diseases.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Hidradenitis suppurativa is linked to autoinflammation and immune system issues.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

The guideline provides recommendations for managing alopecia areata effectively.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.